Dr. Albert Cespedes Jr., MD

Dr. Cespedes practices at Kaiser Permanente Medical Group Bellflower Medical Offices - HOPD in Bellflower, California.

Dr. Cespedes' NPI, 1942527650, was assigned on April 21, 2010. Dr. Cespedes graduated from David Geffen School of Medicine at UCLA in 2010. Dr. Cespedes holds California license A118144.

Dr. Cespedes' primary practice is Kaiser Permanente Medical Group Bellflower Medical Offices - HOPD, at 9400 Rosecrans Avenue, Bellflower, CA 90706.

Dr. Cespedes' primary practice is Kaiser Permanente Medical Group Bellflower Medical Offices - HOPD in Bellflower, California. Dr. Cespedes is also affiliated with Downey Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Cespedes to 1 more breast imaging center, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Cespedes' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cespedes practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Cespedes' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Cespedes is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Cespedes is licensed in California.

Dmand AI lists coronary artery disease and heart failure among the conditions Dr. Cespedes treats.

CMS data shows 13 Medicare services from Dr. Cespedes across 1 procedure code in 2024, for 39 Medicare patients. Medicare paid $619 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Cespedes in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cespedes' median patient age at 65, with 60% women.

In 2024, Dr. Cespedes wrote 1,594 Medicare Part D claims for 341 patients. 80% of them were for generic drugs. CMS names the drug for 1,432 of them, across 29 drugs with 11 or more claims each, at $230,148 in total drug cost. In 2023, CMS named 1,308 claims across 29 drugs.

Dr. Cespedes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cespedes as offering telehealth.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 145 general payments to Dr. Cespedes from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Boston Scientific Corporation paid the most, $1,895.

Dr. Cespedes graduated from David Geffen School of Medicine at UCLA in 2010.

Dr. Cespedes is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.